Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Sims, Jessica D ^a   McCready, Jessica ^a   Jay, Daniel G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; GELATINASE A; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA; PROTEIN HOP; PROTEIN P23; UNCLASSIFIED DRUG; HSP90ALPHA PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER INVASION; CANCER MORTALITY; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; BREAST TUMOR; FEMALE; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 79954994442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018848     Document Type: Article

References (53)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Ernst MF, van de Poll-Franse LV, Roukema JA, Coebergh JW, van Gestel CM, et al. (2007) Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002. Breast 16: 344-351.
3. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM, (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112: 3-25.
4. Nguyen DX, Bos PD, Massague J, (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284.
5. Grenert JP, Johnson BD, Toft DO, (1999) The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes. J Biol Chem 274: 17525-17533.
6. Pratt WB, Toft DO, (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228: 111-133.
7. Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E, (2008) A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J Biol Chem 283: 2031-2041.
8. Kanelakis KC, Murphy PJ, Galigniana MD, Morishima Y, Takayama S, et al. (2000) hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1. Biochemistry 39: 14314-14321.
9. Workman P, (2004) Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone. Cancer Lett 206: 149-157.
10. Maloney A, Workman P, (2002) HSP90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin Biol Ther 2: 3-24.
11. Neckers L, Ivy SP, (2003) Heat shock protein 90. Curr Opin Oncol 15: 419-424.
12. McCready J, Sims JD, Chan D, Jay DG, (2010) Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10: 294.
13. Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, et al. (2004) Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6: 507-514.
14. Jezierska A, Motyl T, (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15: RA32-40.
15. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C, (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424.
16. Ra HJ, Parks WC, (2007) Control of matrix metalloproteinase catalytic activity. Matrix Biol 26: 587-596.
17. Bartsch JE, Staren ED, Appert HE, (2003) Matrix metalloproteinase expression in breast cancer. J Surg Res 110: 383-392.
18. Nagase H, (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151-160.
19. Kosano H, Stensgard B, Charlesworth MC, McMahon N, Toft D, (1998) The assembly of progesterone receptor-hsp90 complexes using purified proteins. J Biol Chem 273: 32973-32979.
20. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, et al. (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275: 3305-3312.
21. Chen JH, Lin HH, Chiang TA, Hsu JD, Ho HH, et al. (2008) Gaseous nitrogen oxide promotes human lung cancer cell line A549 migration, invasion, and metastasis via iNOS-mediated MMP-2 production. Toxicol Sci 106: 364-375.
22. Loftus JP, Belknap JK, Black SJ, (2006) Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet Immunol Immunopathol 113: 267-276.
23. Quesada AR, Barbacid MM, Mira E, Fernandez-Resa P, Marquez G, et al. (1997) Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases. Clin Exp Metastasis 15: 26-32.
24. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, et al. (2003) A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425: 407-410.
25. Buchner J, (1999) Hsp90 & Co.- a holding for folding. Trends Biochem Sci 24: 136-141.
26. Eustace BK, Jay DG, (2004) Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 3: 1098-1100.
27. Pratt WB, Toft DO, (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-360.
28. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE, (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A 87: 364-368.
29. Strongin AY, Marmer BL, Grant GA, Goldberg GI, (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268: 14033-14039.
30. Ratnikov BI, Deryugina EI, Strongin AY, (2002) Gelatin zymography and substrate cleavage assays of matrix metalloproteinase-2 in breast carcinoma cells overexpressing membrane type-1 matrix metalloproteinase. Lab Invest 82: 1583-1590.
31. Lafleur MA, Hollenberg MD, Atkinson SJ, Knauper V, Murphy G, et al. (2001) Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. Biochem J 357: 107-115.
32. Wang AM, Morishima Y, Clapp KM, Peng HM, Pratt WB, et al. (2010) Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation. J Biol Chem 285: 15714-15723.
33. Haas TL, (2005) Endothelial cell regulation of matrix metalloproteinases. Can J Physiol Pharmacol 83: 1-7.
34. Ray JM, Stetler-Stevenson WG, (1995) Gelatinase A activity directly modulates melanoma cell adhesion and spreading. Embo J 14: 908-917.
35. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ, (1997) Matrix metalloproteinase inhibitors. Invest New Drugs 15: 61-75.
36. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
37. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
38. Song X, Luo Y, (2010) The regulatory mechanism of Hsp90alpha secretion from endothelial cells and its role in angiogenesis during wound healing. Biochem Biophys Res Commun.
39. Song X, Wang X, Zhuo W, Shi H, Feng D, et al. (2010) The regulatory mechanism of extracellular Hsp90{alpha} on matrix metalloproteinase-2 (MMP-2) processing and tumor angiogenesis. J Biol Chem.
40. Multhoff G, (2007) Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods 43: 229-237.
41. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C, (2007) Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol 81: 15-27.
42. Becker B, Multhoff G, Farkas B, Wild PJ, Landthaler M, et al. (2004) Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol 13: 27-32.
43. Chen JS, Hsu YM, Chen CC, Chen LL, Lee CC, et al. (2010) Secreted heat shock protein 90{alpha} induces colorectal cancer cell invasion through CD91/LRP-1 and NF-{kappa}B-mediated integrin {alpha}V expression. J Biol Chem.
44. Tsutsumi S, Neckers L, (2007) Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci 98: 1536-1539.
45. Tsutsumi S, Scroggins B, Koga F, Lee MJ, Trepel J, et al. (2008) A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 27: 2478-2487.
46. Chung SW, Lee JH, Choi KH, Park YC, Eo SK, et al. (2009) Extracellular heat shock protein 90 induces interleukin-8 in vascular smooth muscle cells. Biochem Biophys Res Commun 378: 444-449.
47. Li W, Li Y, Guan S, Fan J, Cheng CF, et al. (2007) Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. Embo J 26: 1221-1233.
48. Sidera K, Samiotaki M, Yfanti E, Panayotou G, Patsavoudi E, (2004) Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system. J Biol Chem 279: 45379-45388.
49. Cheng CF, Fan J, Fedesco M, Guan S, Li Y, et al. (2008) Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol 28: 3344-3358.
50. Mickler M, Hessling M, Ratzke C, Buchner J, Hugel T, (2009) The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis. Nat Struct Mol Biol 16: 281-286.
51. Deli T, Csernoch L, (2008) Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. Pathol Oncol Res 14: 219-231.
52. Trautmann A, (2009) Extracellular ATP in the immune system: more than just a "danger signal". Sci Signal 2: pe6.
53. Powers MV, Jones K, Barillari C, Westwood I, van Montfort RL, et al. (2010) Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone? Cell Cycle 9.